Preventive therapy for tuberculosis in HIV infection: the promise and the reality.
O'Brien
R J
RJ
Perriëns
J H
JH
D017088:AIDS-Related Opportunistic Infections / Q000517:prevention & control*; D000328:Adult; D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology; D003362:Cost-Benefit Analysis; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D010349:Patient Compliance; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D018088:Tuberculosis, Multidrug-Resistant / Q000209:etiology / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000209:etiology / Q000517:prevention & control*
D000995:Antitubercular Agents; D007538:Isoniazid